Dolphin Medical Services has accepted the resignation of Vaishnavi Sharma from the dual roles of Company Secretary cum Compliance Officer and Chief Financial Officer. The Board of Directors approved the departure during a meeting held on July 25, 2026, with the resignation taking effect from the close of business hours on July 24, 2026. This leadership change impacts key compliance and financial oversight functions within the organization.

The decision followed recommendations from both the Nomination and Remuneration Committee and the Audit Committee. The company disclosed the outcome pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Additionally, the disclosure aligns with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023.

Key Details

The Board placed on record its appreciation for the services rendered by Vaishnavi Sharma during their tenure. The meeting commenced at 4:30 P.M. (IST) and concluded at 5:00 P.M. (IST). Director Rajesh Kumar Mallour signed the communication to BSE Limited.

The disclosures required under Regulation 30 read with Schedule III, Part A, Para A(7) of the SEBI Listing Regulations were enclosed as Annexure-A in the filing. No reasons for the resignation were specified beyond the standard category of "Resignation as Company Secretary and CFO" in the annexure.

Rarever Financial Advisors Private Limited has fixed July 17, 2026, as the identified date for the proposed open offer to acquire up to 39,25,988 fully paid-up equity shares of Dolphin Medical Services Limited . The offer represents 26.00% of the voting share capital of the target company. Acquirers Mr. Amarandhar Reddy Kotha and Mr. Mallour Rajesh Kumar will purchase these shares from public shareholders at a price of ₹4.80 per equity share.

The Manager to the Offer stated that the identified date is established to determine the names of the shareholders as on that specific date to whom the Letter of Offer would be sent. This disclosure was made in compliance with regulation 18(2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeover) Regulations, 2011.

The open offer process references a Public Announcement dated May 15, 2026, a Detailed Public Statement published on May 22, 2026, and a Draft Letter of Offer dated June 01, 2026. The shares being acquired have a face value of ₹10 each.

Open Offer Details